Last updated: 22 July 2019 at 8:58am EST

Michael J Levernier Net Worth




The estimated Net Worth of Michael J Levernier is at least $1.47 millió dollars as of 11 July 2005. Michael Levernier owns over 3,300 units of Cutera Inc stock worth over $130,584 and over the last 20 years Michael sold CUTR stock worth over $1,337,344.

Michael Levernier CUTR stock SEC Form 4 insiders trading

Michael has made over 38 trades of the Cutera Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Michael sold 3,300 units of CUTR stock worth $54,714 on 11 July 2005.

The largest trade Michael's ever made was selling 3,300 units of Cutera Inc stock on 11 July 2005 worth over $54,714. On average, Michael trades about 2,282 units every 7 days since 2004. As of 11 July 2005 Michael still owns at least 189,252 units of Cutera Inc stock.

You can see the complete history of Michael Levernier stock trades at the bottom of the page.



What's Michael Levernier's mailing address?

Michael's mailing address filed with the SEC is C/O CUTERA, INC., 3240 BAYSHORE BOULEVARD, BRISBANE, CA, 94005.

Insiders trading at Cutera Inc

Over the last 21 years, insiders at Cutera Inc have traded over $58,122,420 worth of Cutera Inc stock and bought 1,064,292 units worth $26,108,997 . The most active insiders traders include Kevin P Connors, J Daniel Plants és David A Gollnick. On average, Cutera Inc executives and independent directors trade stock every 22 days with the average trade being worth of $13,243. The most recent stock trade was executed by Michael Karavitis on 14 May 2024, trading 63,603 units of CUTR stock currently worth $165,368.



What does Cutera Inc do?

cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra



Complete history of Michael Levernier stock trades at Cutera Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Michael J Levernier
VP of Clinical Development
Eladás $54,714
11 Jul 2005
Michael J Levernier
VP of Clinical Development
Eladás $55,704
5 Jul 2005
Michael J Levernier
VP of Clinical Development
Eladás $58,311
24 Jun 2005
Michael J Levernier
VP of Clinical Development
Eladás $53,559
20 Jun 2005
Michael J Levernier
VP of Clinical Development
Eladás $50,622
13 Jun 2005
Michael J Levernier
VP of Clinical Development
Eladás $50,556
6 Jun 2005
Michael J Levernier
VP of Clinical Development
Eladás $50,787
31 May 2005
Michael J Levernier
VP of Clinical Development
Eladás $50,160
23 May 2005
Michael J Levernier
VP of Clinical Development
Eladás $51,315
16 May 2005
Michael J Levernier
VP of Clinical Development
Eladás $54,516
9 May 2005
Michael J Levernier
VP of Clinical Development
Eladás $33,700
2 May 2005
Michael J Levernier
VP of Clinical Development
Eladás $35,540
25 Apr 2005
Michael J Levernier
VP of Clinical Development
Eladás $34,500
18 Apr 2005
Michael J Levernier
VP of Clinical Development
Eladás $39,200
11 Apr 2005
Michael J Levernier
VP of Clinical Development
Eladás $37,300
4 Apr 2005
Michael J Levernier
VP of Clinical Development
Eladás $37,980
28 Mar 2005
Michael J Levernier
VP of Clinical Development
Eladás $34,840
21 Mar 2005
Michael J Levernier
VP of Clinical Development
Eladás $37,360
14 Mar 2005
Michael J Levernier
VP of Clinical Development
Eladás $35,740
7 Mar 2005
Michael J Levernier
VP of Clinical Development
Eladás $32,140
28 Feb 2005
Michael J Levernier
VP of Clinical Development
Eladás $34,180
22 Feb 2005
Michael J Levernier
VP of Clinical Development
Eladás $35,400
14 Feb 2005
Michael J Levernier
VP of Clinical Development
Eladás $27,600
7 Feb 2005
Michael J Levernier
VP of Clinical Development
Eladás $27,240
31 Jan 2005
Michael J Levernier
VP of Clinical Development
Eladás $24,540
24 Jan 2005
Michael J Levernier
VP of Clinical Development
Eladás $24,960
18 Jan 2005
Michael J Levernier
VP of Clinical Development
Eladás $25,300
10 Jan 2005
Michael J Levernier
VP of Clinical Development
Eladás $24,200
3 Jan 2005
Michael J Levernier
VP of Clinical Development
Eladás $24,300
27 Dec 2004
Michael J Levernier
VP of Clinical Development
Eladás $25,300
20 Dec 2004
Michael J Levernier
VP of Clinical Development
Eladás $24,360
13 Dec 2004
Michael J Levernier
VP of Clinical Development
Eladás $23,600
6 Dec 2004
Michael J Levernier
VP of Clinical Development
Eladás $22,720
29 Nov 2004
Michael J Levernier
VP of Clinical Development
Eladás $22,820
22 Nov 2004
Michael J Levernier
VP of Clinical Development
Eladás $20,200
15 Nov 2004
Michael J Levernier
VP of Clinical Development
Eladás $22,400
8 Nov 2004
Michael J Levernier
VP of Clinical Development
Eladás $21,000
1 Nov 2004
Michael J Levernier
VP of Clinical Development
Eladás $18,680
25 Oct 2004


Cutera Inc executives and stock owners

Cutera Inc executives and other stock owners filed with the SEC include: